Trexquant Investment’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-140,325	Closed	-$2.08M	–	1679
2024 Q1	$2.08M	Buy	+140,325	New	+$1.63M	0.04%	635
2023 Q2	–	Sell	-280,846	Closed	-$1.72M	–	1599
2023 Q1	$1.72M	Buy	280,846 +104,220	+59%	+$719K	0.05%	514
2022 Q4	$1.13M	Buy	+176,626	New	+$1.38M	0.03%	606
2022 Q1	–	Sell	-13,657	Closed	-$261K	–	1532
2021 Q4	$261K	Sell	13,657 -9,995	-42%	-$220K	0.02%	1001
2021 Q3	$583K	Buy	+23,652	New	+$557K	0.05%	477
2021 Q2	–	Sell	-34,757	Closed	-$1.1M	–	1286
2021 Q1	$1.1M	Buy	+34,757	New	+$1.44M	0.1%	253
2020 Q4	–	Sell	-16,733	Closed	-$551K	–	1245
2020 Q3	$551K	Sell	16,733 -31,137	-65%	-$955K	0.04%	638
2020 Q2	$1.31M	Buy	+47,870	New	+$1.57M	0.09%	312
2019 Q2	–	Sell	-55,079	Closed	-$524K	–	964
2019 Q1	$524K	Buy	+55,079	New	+$535K	0.04%	576
2018 Q4	–	Sell	-24,732	Closed	-$278K	–	1157
2018 Q3	$278K	Buy	24,732 +14,618	+145%	+$207K	0.02%	708
2018 Q2	$129K	Buy	+10,114	New	+$148K	0.01%	825
2018 Q1	–	Sell	-15,464	Closed	-$124K	–	1220
2017 Q4	$124K	Sell	15,464 -24,126	-61%	-$194K	0.01%	994
2017 Q3	$307K	Buy	+39,590	New	+$251K	0.08%	458
2017 Q2	–	Sell	-26,449	Closed	-$197K	–	956
2017 Q1	$197K	Buy	+26,449	New	+$194K	0.03%	964
2016 Q4	–	Sell	-14,652	Closed	-$121K	–	1040
2016 Q3	$121K	Buy	+14,652	New	+$124K	0.03%	681
2016 Q2	–	Sell	-27,660	Closed	-$141K	–	970
2016 Q1	$141K	Buy	+27,660	New	+$151K	0.02%	861